0000914190-17-000238.txt : 20170815
0000914190-17-000238.hdr.sgml : 20170815
20170815164427
ACCESSION NUMBER: 0000914190-17-000238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170812
FILED AS OF DATE: 20170815
DATE AS OF CHANGE: 20170815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kummeth Charles R.
CENTRAL INDEX KEY: 0001534980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 171034341
MAIL ADDRESS:
STREET 1: 425 MARTINGALE ROAD
STREET 2: SUITE 1000
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173-2213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-08-12
0000842023
BIO-TECHNE Corp
TECH
0001534980
Kummeth Charles R.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
1
0
0
Chief Executive Officer
Common Stock
2017-08-12
4
M
0
9248
A
70278
D
Stock Option (Right to Buy)
67.46
2020-04-01
Common Stock
65000
65000
D
Stock Option (Right to Buy)
67.46
2020-04-01
Common Stock
50000
50000
D
Stock Option (Right to Buy)
86.25
2021-04-01
Common Stock
46316
46316
D
Stock Option (Right to Buy)
94.35
2017-08-12
4
A
0
66849
0
A
2021-08-12
Common Stock
66849
66849
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
79517
79517
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
119275
119275
D
Restricted Stock Unit
Common Stock
17283
17283
D
Stock Option (Right to Buy)
106.59
2023-08-18
Common Stock
102779
102779
D
Stock Option (Right to Buy)
106.59
2023-08-18
Common Stock
154169
154169
D
Restricted Stock Unit
Common Stock
24979
24979
D
On August 12, 2014, the reporting person was granted 11,129 restricted stock units (previously reported). The restricted stock units would vest in full or in part on August 12, 2017 if certain performance goals were achieved during each of the 2015, 2016 and 2017 fiscal years. The performance criteria was determined, resulting in the restricted stock unit vesting as to 9,248 shares.
Restricted stock units convert into common stock on a one-for-one basis.
Includes (i) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (ii) 3,841 shares for which the risks of forfeiture will lapse on August 7, 2018; and (iii) 16,653 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2017, August 18, 2018 and August 18, 2019.
Fully exercisable.
The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.
Fully exercisable pursuant to achievement of performance goals.
On August 12, 2014, the reporting person was granted an option to purchase 80,460 shares of common stock (previously reported). The option would vest in full or in part on August 12, 2017 if certain performance goals were achieved during each of the 2015, 2016 and 2017 fiscal years. The performance criteria was determined, resulting in the option vesting as to 66,849 shares.
19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
/s/ Melodie R. Rose as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed.
2017-08-15